Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
about
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulinMatrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2: BINDING STUDIES AND CRYSTAL STRUCTURETotal conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzymeInactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria.Progress in matrix metalloproteinase research.Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidantsADAMTS13 and 15 are not regulated by the full length and N-terminal domain forms of TIMP-1, -2, -3 and -4.Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha.Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
P2860
Q24646364-F9E4A8F5-00FA-4061-BDD5-CF853D43AC57Q27678085-703D21EE-14C5-4CBB-B14E-D3B1CDE428EFQ28235218-A0F77C2D-B1EE-46BD-94A5-F753F6004DAFQ33581798-F3AF7643-DA23-4897-86B1-8C8986CF86B0Q33608536-B3CBE415-1B79-4FF5-A7D5-7A79F71E6A54Q34513677-78B4C014-3B37-4040-AA9A-BE0B53A718B4Q34777834-72D4CC39-D313-4F1F-A82F-AEDC70FDEBFDQ36104532-32DBC59F-0D43-4AE8-99CA-1419E1B31D98Q36502133-A4607DE7-50C9-467B-B1FF-AD7A01053AC4Q39704977-45B65FE6-BD1D-4FD4-8D92-85602BDCA949Q51380060-4F2DB189-17BC-4AC5-8EE6-5DD9BBB5892F
P2860
Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Delineating the molecular basi ...... actor-alpha-converting enzyme.
@en
Delineating the molecular basi ...... actor-alpha-converting enzyme.
@nl
type
label
Delineating the molecular basi ...... actor-alpha-converting enzyme.
@en
Delineating the molecular basi ...... actor-alpha-converting enzyme.
@nl
prefLabel
Delineating the molecular basi ...... actor-alpha-converting enzyme.
@en
Delineating the molecular basi ...... actor-alpha-converting enzyme.
@nl
P2093
P2860
P356
P1476
Delineating the molecular basi ...... actor-alpha-converting enzyme.
@en
P2093
Gillian Murphy
Magdalini Rapti
Meng-Huee Lee
P2860
P304
45121-45129
P356
10.1074/JBC.M406611200
P407
P577
2004-08-12T00:00:00Z